Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

The Cannabis Question: Marijuana and Workplace Safety?

With greater legalization and public approval, the question of safety grows more important.
Summer 2022

Out of Stock: Medical Supply Chain Shortages Impacting Workers’ Comp

Ancillary medical product and service shortages and how to manage them.
Summer 2022

Social Influencers: The Role of Social Determinants of Health in Injured Worker Recovery

Gaining visibility into Social Determinants of Health that intersect with workplace injury and recovery
Summer 2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

As the market grows, it becomes necessary to understand efficacy, costs, and alternatives.
Mar 2024

CWCI Reports on Cumulative Trauma in Litigated Claims

Tenure more than age and other factors had a higher association with cumulative trauma claims.
Mar 2024

AI Utilization Review Bills Appear Across the Country

California, Georgia, New York, Oklahoma, and Pennsylvania could start a national trend.
Mar 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Saliva Test with At-Home Collection Authorized

Saliva samples collected at-home must be sent to the designated lab.
May 2020

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
May 2020
1 11 12 13 14 15 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle